Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China

医学 白喉 血清流行率 抗体 接种疫苗 病毒学 免疫学 血清学
作者
Qi Zhang,Fu-lian Han,Nie Qing,Hongyu Ren,Baoqiang Zhang,Qiyong Liu,Qiushui He,Zhujun Shao
出处
期刊:Journal of Infection [Elsevier]
卷期号:63 (6): 441-446 被引量:31
标识
DOI:10.1016/j.jinf.2011.07.018
摘要

Despite extensive childhood immunization, pertussis remains one of the world's leading causes of vaccine-preventable deaths. Incidence of pertussis in adolescents and adults has increased in many countries despite high vaccination coverage. In China, booster vaccinations against diphtheria, tetanus and pertussis are not used in adults, and little is known about pertussis incidence in the age group. The aim of this study was to determine seroprevalence of IgG antibodies to pertussis toxin (PT) and diphtheria among adults in China.Blood samples were obtained from 210 healthy adults aged 18-50 years in Weifang city, China during the period of May and June 2010. Serum IgG antibodies against PT (anti-PT IgG) and diphtheria were determined by the commercial ELISA kits, respectively. According to the kit, concentration of anti-PT IgG higher than 30 IU/mL was considered positive. An antibody concentration of ≥ 0.1 IU/mL was defined as evidence of seroprotection against diphtheria.The mean concentration of anti-PT IgG antibodies was 9.95 IU/mL (95% confidence interval (CI) 8.45-11.44). Eleven (5.24%) of the studied subjects were proved to be seropositive to pertussis. Of the 210 subjects, 161 (76.6%) had anti-diphtheria antibody concentration ≥ 0.1 IU/mL and 49 (23.3%) had the antibody concentration between 0.01 and 0.099 IU/mL.Our study indicated that about 5% of adults aged 18-50 years had positive anti-PT IgG antibodies, suggesting that adult pertussis is not uncommon in China. Although a high proportion of studied subjects had a protective level of immunity against diphtheria, the antibody level decreased with the increasing age of adults. Booster vaccinations against pertussis should be considered in adults in China.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
datiancaihaha发布了新的文献求助10
2秒前
秦桂敏完成签到 ,获得积分10
2秒前
量子星尘发布了新的文献求助30
2秒前
2秒前
3秒前
3秒前
4秒前
4秒前
4秒前
4秒前
5秒前
peter完成签到,获得积分10
5秒前
5秒前
五山第一院士完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
友好代亦完成签到,获得积分10
7秒前
7秒前
年轻绮波完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
baimo完成签到,获得积分10
8秒前
8秒前
羊羊羊完成签到 ,获得积分10
8秒前
8秒前
8秒前
8秒前
8秒前
8秒前
9秒前
9秒前
9秒前
9秒前
10秒前
10秒前
10秒前
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
从k到英国情人 1500
Ägyptische Geschichte der 21.–30. Dynastie 1100
„Semitische Wissenschaften“? 1100
Real World Research, 5th Edition 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5734851
求助须知:如何正确求助?哪些是违规求助? 5356584
关于积分的说明 15327858
捐赠科研通 4879364
什么是DOI,文献DOI怎么找? 2621846
邀请新用户注册赠送积分活动 1571071
关于科研通互助平台的介绍 1527841